All PlansAdministrativeLow impact
Recall: Brimonidine
UPMC Health Plan·Ophthalmology, Family Medicine, Internal Medicine·Pharmacy
We identified it
Jun 20, 2026
Summary
Apotex Corp. is voluntarily recalling six lots of Brimonidine Tartrate Ophthalmic Solution 0.15% due to cracked bottle caps. This medication is used to treat elevated eye pressure in glaucoma and ocular hypertension patients.
Action Required
Immediately: Clinical staff should check current inventory of Brimonidine Tartrate Ophthalmic Solution 0.15% from Apotex Corp and remove recalled lots. Notify patients using affected lots to contact their pharmacy for replacement medication. No billing system changes required as this is a drug recall notice.